Global Vaccine Adjuvants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 20-Jun-2018
No. of pages: 148

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Scope of the Report:

This report focuses on the Vaccine Adjuvants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine adjuvants. And the proportion of human vaccine adjuvants in 2016 is about 52.4%. The veterinary vaccine adjuvants in 2015 are about 47.6%.

The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 56.3%. The Subcutaneous in 2016 is about 29%.

The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 55.5%. The Subcutaneous in 2016 is about 28.8%.

The worldwide market for Vaccine Adjuvants is expected to grow at a CAGR of roughly 10.3% over the next five years, will reach 1010 million US$ in 2023, from 560 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- SEPPIC

- SDA BIO

- Brenntag Biosector

- SPI Pharma

- MVP Laboratories

- Tj Kaiwei

- Novavax

- Zhuoyue

- Aphios

- GSK

- CSL Limited

- Brenntag Biosector

- SEPPIC

- SPI Pharma

- Novavax

- Avanti Polar Lipids

- Aphios

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Oral

- Subcutaneous

- Intramuscular

- Others

Market Segment by Applications, can be divided into

- Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)

- Human Vaccine Adjuvants (Research Applications, Commercial Applications)

There are 15 Chapters to deeply display the global Vaccine Adjuvants market.

Chapter 1, to describe Vaccine Adjuvants Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Vaccine Adjuvants, with sales, revenue, and price of Vaccine Adjuvants, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Vaccine Adjuvants, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Vaccine Adjuvants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Subcutaneous
1.2.3 Intramuscular
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 SEPPIC
2.1.1 Business Overview
2.1.2 Vaccine Adjuvants Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 SDA BIO
2.2.1 Business Overview
2.2.2 Vaccine Adjuvants Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Brenntag Biosector
2.3.1 Business Overview
2.3.2 Vaccine Adjuvants Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 SPI Pharma
2.4.1 Business Overview
2.4.2 Vaccine Adjuvants Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 MVP Laboratories
2.5.1 Business Overview
2.5.2 Vaccine Adjuvants Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Tj Kaiwei
2.6.1 Business Overview
2.6.2 Vaccine Adjuvants Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novavax
2.7.1 Business Overview
2.7.2 Vaccine Adjuvants Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Zhuoyue
2.8.1 Business Overview
2.8.2 Vaccine Adjuvants Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aphios
2.9.1 Business Overview
2.9.2 Vaccine Adjuvants Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GSK
2.10.1 Business Overview
2.10.2 Vaccine Adjuvants Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 CSL Limited
2.11.1 Business Overview
2.11.2 Vaccine Adjuvants Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Brenntag Biosector
2.12.1 Business Overview
2.12.2 Vaccine Adjuvants Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 SEPPIC
2.13.1 Business Overview
2.13.2 Vaccine Adjuvants Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 SPI Pharma
2.14.1 Business Overview
2.14.2 Vaccine Adjuvants Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Novavax
2.15.1 Business Overview
2.15.2 Vaccine Adjuvants Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Avanti Polar Lipids
2.16.1 Business Overview
2.16.2 Vaccine Adjuvants Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Aphios
2.17.1 Business Overview
2.17.2 Vaccine Adjuvants Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Vaccine Adjuvants Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Vaccine Adjuvants Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Vaccine Adjuvants Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccine Adjuvants Manufacturer Market Share in 2017
3.3.2 Top 6 Vaccine Adjuvants Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Vaccine Adjuvants Market Analysis by Regions
4.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccine Adjuvants Sales and Market Share by Regions (2013-2018)
4.1.2 Global Vaccine Adjuvants Revenue and Market Share by Regions (2013-2018)
4.2 North America Vaccine Adjuvants Sales and Growth Rate (2013-2018)
4.3 Europe Vaccine Adjuvants Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Vaccine Adjuvants Sales and Growth Rate (2013-2018)
4.5 South America Vaccine Adjuvants Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Vaccine Adjuvants Sales and Growth Rate (2013-2018)
5 North America Vaccine Adjuvants by Countries
5.1 North America Vaccine Adjuvants Sales, Revenue and Market Share by Countries
5.1.1 North America Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
5.1.2 North America Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
5.2 United States Vaccine Adjuvants Sales and Growth Rate (2013-2018)
5.3 Canada Vaccine Adjuvants Sales and Growth Rate (2013-2018)
5.4 Mexico Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6 Europe Vaccine Adjuvants by Countries
6.1 Europe Vaccine Adjuvants Sales, Revenue and Market Share by Countries
6.1.1 Europe Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
6.2 Germany Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6.3 UK Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6.4 France Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6.5 Russia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6.6 Italy Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7 Asia-Pacific Vaccine Adjuvants by Countries
7.1 Asia-Pacific Vaccine Adjuvants Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
7.2 China Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7.3 Japan Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7.4 Korea Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7.5 India Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
8 South America Vaccine Adjuvants by Countries
8.1 South America Vaccine Adjuvants Sales, Revenue and Market Share by Countries
8.1.1 South America Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
8.1.2 South America Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Vaccine Adjuvants Sales and Growth Rate (2013-2018)
8.3 Argentina Vaccine Adjuvants Sales and Growth Rate (2013-2018)
8.4 Colombia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9 Middle East and Africa Vaccine Adjuvants by Countries
9.1 Middle East and Africa Vaccine Adjuvants Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9.3 UAE Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9.4 Egypt Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9.5 Nigeria Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9.6 South Africa Vaccine Adjuvants Sales and Growth Rate (2013-2018)
10 Global Vaccine Adjuvants Market Segment by Type
10.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Vaccine Adjuvants Sales and Market Share by Type (2013-2018)
10.1.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 Subcutaneous Sales Growth and Price
10.3.1 Global Subcutaneous Sales Growth (2013-2018)
10.3.2 Global Subcutaneous Price (2013-2018)
10.4 Intramuscular Sales Growth and Price
10.4.1 Global Intramuscular Sales Growth (2013-2018)
10.4.2 Global Intramuscular Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Vaccine Adjuvants Market Segment by Application
11.1 Global Vaccine Adjuvants Sales Market Share by Application (2013-2018)
11.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2013-2018)
11.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2013-2018)
12 Vaccine Adjuvants Market Forecast (2018-2023)
12.1 Global Vaccine Adjuvants Sales, Revenue and Growth Rate (2018-2023)
12.2 Vaccine Adjuvants Market Forecast by Regions (2018-2023)
12.2.1 North America Vaccine Adjuvants Market Forecast (2018-2023)
12.2.2 Europe Vaccine Adjuvants Market Forecast (2018-2023)
12.2.3 Asia-Pacific Vaccine Adjuvants Market Forecast (2018-2023)
12.2.4 South America Vaccine Adjuvants Market Forecast (2018-2023)
12.2.5 Middle East and Africa Vaccine Adjuvants Market Forecast (2018-2023)
12.3 Vaccine Adjuvants Market Forecast by Type (2018-2023)
12.3.1 Global Vaccine Adjuvants Sales Forecast by Type (2018-2023)
12.3.2 Global Vaccine Adjuvants Market Share Forecast by Type (2018-2023)
12.4 Vaccine Adjuvants Market Forecast by Application (2018-2023)
12.4.1 Global Vaccine Adjuvants Sales Forecast by Application (2018-2023)
12.4.2 Global Vaccine Adjuvants Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Vaccine Adjuvants Picture
Table Product Specifications of Vaccine Adjuvants
Figure Global Sales Market Share of Vaccine Adjuvants by Types in 2017
Table Vaccine Adjuvants Types for Major Manufacturers
Figure Oral Picture
Figure Subcutaneous Picture
Figure Intramuscular Picture
Figure Others Picture
Figure Vaccine Adjuvants Sales Market Share by Applications in 2017
Figure Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure Human Vaccine Adjuvants (Research Applications, Commercial Applications) Picture
Figure United States Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure France Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure UK Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure China Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure India Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Vaccine Adjuvants Revenue (Value) and Growth Rate (2013-2023)
Table SEPPIC Basic Information, Manufacturing Base and Competitors
Table SEPPIC Vaccine Adjuvants Type and Applications
Table SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SDA BIO Basic Information, Manufacturing Base and Competitors
Table SDA BIO Vaccine Adjuvants Type and Applications
Table SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table Brenntag Biosector Vaccine Adjuvants Type and Applications
Table Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SPI Pharma Basic Information, Manufacturing Base and Competitors
Table SPI Pharma Vaccine Adjuvants Type and Applications
Table SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MVP Laboratories Basic Information, Manufacturing Base and Competitors
Table MVP Laboratories Vaccine Adjuvants Type and Applications
Table MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Tj Kaiwei Basic Information, Manufacturing Base and Competitors
Table Tj Kaiwei Vaccine Adjuvants Type and Applications
Table Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Vaccine Adjuvants Type and Applications
Table Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Zhuoyue Basic Information, Manufacturing Base and Competitors
Table Zhuoyue Vaccine Adjuvants Type and Applications
Table Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aphios Basic Information, Manufacturing Base and Competitors
Table Aphios Vaccine Adjuvants Type and Applications
Table Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Vaccine Adjuvants Type and Applications
Table GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Vaccine Adjuvants Type and Applications
Table CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Brenntag Biosector Basic Information, Manufacturing Base and Competitors
Table Brenntag Biosector Vaccine Adjuvants Type and Applications
Table Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SEPPIC Basic Information, Manufacturing Base and Competitors
Table SEPPIC Vaccine Adjuvants Type and Applications
Table SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SPI Pharma Basic Information, Manufacturing Base and Competitors
Table SPI Pharma Vaccine Adjuvants Type and Applications
Table SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novavax Basic Information, Manufacturing Base and Competitors
Table Novavax Vaccine Adjuvants Type and Applications
Table Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table Avanti Polar Lipids Vaccine Adjuvants Type and Applications
Table Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Aphios Basic Information, Manufacturing Base and Competitors
Table Aphios Vaccine Adjuvants Type and Applications
Table Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Vaccine Adjuvants Sales by Manufacturer (2016-2017)
Figure Global Vaccine Adjuvants Sales Market Share by Manufacturer in 2016
Figure Global Vaccine Adjuvants Sales Market Share by Manufacturer in 2017
Table Global Vaccine Adjuvants Revenue by Manufacturer (2016-2017)
Figure Global Vaccine Adjuvants Revenue Market Share by Manufacturer in 2016
Figure Global Vaccine Adjuvants Revenue Market Share by Manufacturer in 2017
Figure Top 3 Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Vaccine Adjuvants Manufacturer (Revenue) Market Share in 2017
Figure Global Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Global Vaccine Adjuvants Revenue and Growth Rate (2013-2018)
Table Global Vaccine Adjuvants Sales by Regions (2013-2018)
Table Global Vaccine Adjuvants Sales Market Share by Regions (2013-2018)
Table Global Vaccine Adjuvants Revenue by Regions (2013-2018)
Figure Global Vaccine Adjuvants Revenue Market Share by Regions in 2013
Figure Global Vaccine Adjuvants Revenue Market Share by Regions in 2017
Figure North America Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Europe Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure South America Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure North America Vaccine Adjuvants Revenue and Growth Rate (2013-2018)
Table North America Vaccine Adjuvants Sales by Countries (2013-2018)
Table North America Vaccine Adjuvants Sales Market Share by Countries (2013-2018)
Figure North America Vaccine Adjuvants Sales Market Share by Countries in 2013
Figure North America Vaccine Adjuvants Sales Market Share by Countries in 2017
Table North America Vaccine Adjuvants Revenue by Countries (2013-2018)
Table North America Vaccine Adjuvants Revenue Market Share by Countries (2013-2018)
Figure North America Vaccine Adjuvants Revenue Market Share by Countries in 2013
Figure North America Vaccine Adjuvants Revenue Market Share by Countries in 2017
Figure United States Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Canada Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Mexico Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Europe Vaccine Adjuvants Revenue and Growth Rate (2013-2018)
Table Europe Vaccine Adjuvants Sales by Countries (2013-2018)
Table Europe Vaccine Adjuvants Sales Market Share by Countries (2013-2018)
Table Europe Vaccine Adjuvants Revenue by Countries (2013-2018)
Figure Europe Vaccine Adjuvants Revenue Market Share by Countries in 2016
Figure Europe Vaccine Adjuvants Revenue Market Share by Countries in 2017
Figure Germany Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure UK Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure France Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Russia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Italy Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Vaccine Adjuvants Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Vaccine Adjuvants Sales by Countries (2013-2018)
Table Asia-Pacific Vaccine Adjuvants Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Vaccine Adjuvants Sales Market Share by Countries 2017
Table Asia-Pacific Vaccine Adjuvants Revenue by Countries (2013-2018)
Figure Asia-Pacific Vaccine Adjuvants Revenue Market Share by Countries 2017
Figure China Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Japan Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Korea Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure India Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure South America Vaccine Adjuvants Revenue and Growth Rate (2013-2018)
Table South America Vaccine Adjuvants Sales by Countries (2013-2018)
Table South America Vaccine Adjuvants Sales Market Share by Countries (2013-2018)
Figure South America Vaccine Adjuvants Sales Market Share by Countries in 2017
Table South America Vaccine Adjuvants Revenue by Countries (2013-2018)
Table South America Vaccine Adjuvants Revenue Market Share by Countries (2013-2018)
Figure South America Vaccine Adjuvants Revenue Market Share by Countries in 2017
Figure Brazil Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Argentina Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Colombia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Vaccine Adjuvants Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Vaccine Adjuvants Sales by Countries (2013-2018)
Table Middle East and Africa Vaccine Adjuvants Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Vaccine Adjuvants Sales Market Share by Countries in 2017
Table Middle East and Africa Vaccine Adjuvants Revenue by Countries (2013-2018)
Table Middle East and Africa Vaccine Adjuvants Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Vaccine Adjuvants Revenue Market Share by Countries in 2013
Figure Middle East and Africa Vaccine Adjuvants Revenue Market Share by Countries in 2017
Figure Saudi Arabia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure UAE Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Egypt Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure Nigeria Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Figure South Africa Vaccine Adjuvants Sales and Growth Rate (2013-2018)
Table Global Vaccine Adjuvants Sales by Type (2013-2018)
Table Global Vaccine Adjuvants Sales Share by Type (2013-2018)
Table Global Vaccine Adjuvants Revenue by Type (2013-2018)
Table Global Vaccine Adjuvants Revenue Share by Type (2013-2018)
Figure Global Oral Sales Growth (2013-2018)
Figure Global Oral Price (2013-2018)
Figure Global Subcutaneous Sales Growth (2013-2018)
Figure Global Subcutaneous Price (2013-2018)
Figure Global Intramuscular Sales Growth (2013-2018)
Figure Global Intramuscular Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Vaccine Adjuvants Sales by Application (2013-2018)
Table Global Vaccine Adjuvants Sales Share by Application (2013-2018)
Figure Global Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2013-2018)
Figure Global Vaccine Adjuvants Sales, Revenue and Growth Rate (2018-2023)
Table Global Vaccine Adjuvants Sales Forecast by Regions (2018-2023)
Table Global Vaccine Adjuvants Market Share Forecast by Regions (2018-2023)
Figure North America Sales Vaccine Adjuvants Market Forecast (2018-2023)
Figure Europe Sales Vaccine Adjuvants Market Forecast (2018-2023)
Figure Asia-Pacific Sales Vaccine Adjuvants Market Forecast (2018-2023)
Figure South America Sales Vaccine Adjuvants Market Forecast (2018-2023)
Figure Middle East and Africa Sales Vaccine Adjuvants Market Forecast (2018-2023)
Table Global Vaccine Adjuvants Sales Forecast by Type (2018-2023)
Table Global Vaccine Adjuvants Market Share Forecast by Type (2018-2023)
Table Global Vaccine Adjuvants Sales Forecast by Application (2018-2023)
Table Global Vaccine Adjuvants Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs